ID

27452

Beschrijving

Study ID: 103094 Clinical Study ID: ARI103094 Study Title: ARI103094-Follow-Up Study for REDUCE Study Subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00883909 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: dutasteride Trade Name: Zytefor,Zyfetor,Duagen,Avolve,Avodart,Avidart Study Indication: Neoplasms, Prostate

Trefwoorden

Versies (2)
  1. 15-11-17 15-11-17 -
  2. 26-11-17 26-11-17 -
Houder van rechten

GlaxoSmithKline

Geüploaded op

15 november 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Concomitant Medications GSK study Prostatic neoplasms NCT00883909

Engels

Concomitant Medications GSK study Prostatic neoplasms NCT00883909

1 Formulieren  
Administrative data
Beschrijving

Administrative data

Session number
Beschrijving

Session number

Datatype

integer

Subject number
Beschrijving

Subject number

Datatype

text

Intake of concomitant Medications
Beschrijving

Intake of concomitant Medications

Were any chronic concomitant medications taken by the subject during the Follow-Up study?
Beschrijving

Check that either the YES or NO box at the top of the page is selected. • If NO is selected, check that no applicable concomitant medications are present. • If YES is selected, check that at least one applicable concomitant medication is present. If YES, record below.

Datatype

text

Record of Concomitant Medications
Beschrijving

Record of Concomitant Medications

Drug (Trade name preferred)
Beschrijving

Check that the drug name (trade name preferred) is spelled correctly. If medication is given to treat a serious adverse event (SAE), then the event must be recorded on the SERIOUS ADVERSE EVENT page(s).

Datatype

text

Dose
Beschrijving

Dose

Datatype

float

Units
Beschrijving

Units

Datatype

text

Frequency
Beschrijving

Frequency

Datatype

text

Route
Beschrijving

Route

Datatype

text

Date Started
Beschrijving

Check that either the ‘Date started’ is completed or ‘started Pre-Follow Up Study’ is completed. At least one must be completed, but it is acceptable if both are completed. • If both ‘Date started’ and ‘started Pre-Follow Up Study’ are completed, check that the start date is pre-study.

Datatype

date

Started Pre- Follow Up Study
Beschrijving

Check that either the ‘Date started’ is completed or ‘started Pre-Follow Up Study’ is completed. At least one must be completed, but it is acceptable if both are completed. • If both ‘Date started’ and ‘started Pre-Follow Up Study’ are completed, check that the start date is pre-study.

Datatype

boolean

Date Stopped
Beschrijving

Check that either the ‘Date stopped’ box is completed or the ‘continued Post-Follow Up Study’ is completed. Only one must be completed. • Check that the drug start date is before or equal to the drug stop date.

Datatype

date

Continued Post- Follow Up Study
Beschrijving

Check that either the ‘Date stopped’ box is completed or the ‘continued Post-Follow Up Study’ is completed. Only one must be completed.

Datatype

boolean

Conditions Treated / Indication
Beschrijving

Indication

Datatype

text

Prophylaxis
Beschrijving

Prophylaxis

Datatype

text

Was drug administered for an SAE?
Beschrijving

If the concomitant medication was taken for a serious adverse event (SAE), check that the event is entered on the SERIOUS ADVERSE EVENT page(s) and that the dates are consistent with the event.

Datatype

text

Terug naar het begin van de pagina

Similar models

Concomitant Medications GSK study Prostatic neoplasms NCT00883909

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Administrative data
Session number
Item
Session number
integer
Subject number
Item
Subject number
text
Item Group
Intake of concomitant Medications
Item
Were any chronic concomitant medications taken by the subject during the Follow-Up study?
text
concomitant medications intake
Code List
Were any chronic concomitant medications taken by the subject during the Follow-Up study?
CL Item
Yes (Y)
CL Item
No (N)
Item Group
Record of Concomitant Medications
Drug
Item
Drug (Trade name preferred)
text
Dose
Item
Dose
float
Units
Item
Units
text
Frequency
Item
Frequency
text
Route
Item
Route
text
Date Started
Item
Date Started
date
Started Pre- Follow Up Study
Item
Started Pre- Follow Up Study
boolean
Date Stopped
Item
Date Stopped
date
Continued Post- Follow Up Study
Item
Continued Post- Follow Up Study
boolean
Indication
Item
Conditions Treated / Indication
text
Item
Prophylaxis
text
concomitant medications intake
Code List
Prophylaxis
CL Item
Yes (Y)
CL Item
No (N)
Item
Was drug administered for an SAE?
text
concomitant medications intake
Code List
Was drug administered for an SAE?
CL Item
Yes (Y)
CL Item
No (N)
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial